Sinopharm
1099.HK
#2705
Rank
NZ$11.44 B
Marketcap
NZ$3.67
Share price
-0.82%
Change (1 day)
-8.64%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Earnings for Sinopharm (1099.HK)

Earnings in 2025: NZ$4.14 Billion

According to Sinopharm's latest financial reports the company's current earnings are NZ$82.21 Billion. In 2025 the company made an earning of NZ$4.14 Billion, an increase over its 2024 earnings that were of NZ$3.88 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sinopharm from 2006 to 2025

Annual earnings

Year Earnings Change
2025NZ$4.14 B6.59%
2024NZ$3.88 B-27.86%
2023NZ$5.39 B-0.73%
2022NZ$5.43 B-1.72%
2021NZ$5.52 B11.7%
2020NZ$4.94 B18.44%
2019NZ$4.17 B10.85%
2018NZ$3.76 B3.05%
2017NZ$3.65 B36.48%
2016NZ$2.67 B7.11%
2015NZ$2.50 B12.38%
2014NZ$2.22 B25.05%
2013NZ$1.78 B22.54%
2012NZ$1.45 B35.43%
2011NZ$1.07 B52.24%
2010NZ$0.70 B30.99%
2009NZ$0.53 B60.59%
2008NZ$0.33 B48.29%
2007NZ$0.22 B123.29%
2006NZ$0.10 B